Suzhou Basecare Medical Corporation Limited Stock
Equities
2170
CNE100004BC1
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 HKD | +5.96% | +14.93% | -1.70% |
Sales 2024 * | 459M 63.33M 495M 86.68M | Sales 2025 * | - | Capitalization | 585M 80.84M 631M 111M |
---|---|---|---|---|---|
Net income 2024 * | -78M -10.77M -84.14M -14.75M | Net income 2025 * | - | EV / Sales 2024 * | 1.28 x |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.27
x | P/E ratio 2025 * |
-
| Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.54% |
1 day | +5.96% | ||
1 week | +14.93% | ||
Current month | +8.45% | ||
1 month | +19.69% | ||
3 months | +8.45% | ||
6 months | -15.69% | ||
Current year | -1.70% |
Managers | Title | Age | Since |
---|---|---|---|
Bo Liang
CEO | Chief Executive Officer | 44 | 10-12-13 |
Le Jun Yin
DFI | Director of Finance/CFO | 39 | 22-11-27 |
Mao She Rui
COO | Chief Operating Officer | 36 | 14-11-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xi Xiong Kang
BRD | Director/Board Member | 72 | 21-01-15 |
Bo Liang
CEO | Chief Executive Officer | 44 | 10-12-13 |
Ling Yin Kong
CTO | Chief Tech/Sci/R&D Officer | 44 | 11-06-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 2.31 | +5.96% | 95,000 |
24-05-02 | 2.18 | +2.35% | 115,000 |
24-04-30 | 2.13 | -0.47% | 1,000 |
24-04-29 | 2.14 | +6.47% | 188,000 |
24-04-26 | 2.01 | +0.50% | 31,500 |
Delayed Quote Hong Kong S.E., May 03, 2024 at 04:09 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.70% | 80.88M | |
-18.58% | 8.3B | |
+47.25% | 3.78B | |
-8.58% | 2.47B | |
-38.71% | 2.46B | |
-10.06% | 2.31B | |
-5.44% | 1.95B | |
-17.79% | 1.59B | |
-40.78% | 1.21B | |
+6.69% | 1.1B |
- Stock Market
- Equities
- 2170 Stock